Correlation between Growth Curves and Killing Curves of Escherichia coli in the Presence of Fleroxacin and Ampicillin
- 1 January 1989
- journal article
- research article
- Published by S. Karger AG in Chemotherapy
- Vol. 35 (6) , 423-430
- https://doi.org/10.1159/000238706
Abstract
Fleroxacin, a new long-acting quinolone, induces rapid killing and bacterial filamentation as do other quinolones. Ten strains of Escherichia coli were exposed comparatively to fleroxacin and ampicillin in order to determine the effect of sub- and supra-inhibitory concentrations of each of these two compounds on turbidimetric growth curves and viable counts. By comparing the maximal early increase in optical density (OD, PIOD) as colony-forming units per milliliter (CFU/ml) after 2 and 6 h of exposure to antibiotics, we observed a reduced number of CFU/ml in comparison with the control after the 2-hour exposure at 1/4 the minimum inhibition concentration (MIC) and after 6 h at 1/8 MIC, but a high OD value was also seen among the fleroxacin exposed bacteria. For ampicillin, PIOD rates and killing rates were slower and dose dependent. This discrepancy was due to filament formation, which increased the PIOD value to the same extent as the control curve. After exposure to fleroxacin at 1/2 MIC the PIOD decreased significantly and after 2 and 6 h E. coli killing rates of 99 and 99.9%, respectively, were observed. With exposure to 2 and 4 x MIC, both PIOD values and CFU/ml decreased substantially. Combined analysis of continuous turbidimetric monitoring and viable counts showed that subinhibitory concentrations of fleroxacin and p-lactam had different effects on E. coli. Fleroxacin’s rapid killing rate, despite filament formation, contrasted with the result obtained with ampicillin. The minimum antibiotic concentration of fleroxacin against E. coli was around Vs MIC.424, Yourassowsky/Van der Linden/CrokaertKeywords
This publication has 9 references indexed in Scilit:
- Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12Antimicrobial Agents and Chemotherapy, 1988
- In vitro activity of the new 4-quinolone compound RO 23-6240European Journal of Clinical Microbiology & Infectious Diseases, 1987
- Monocyclic and tricyclic analogs of quinolones: mechanism of actionAntimicrobial Agents and Chemotherapy, 1987
- Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinoloneAntimicrobial Agents and Chemotherapy, 1987
- The response of Escherichia coli to ciprofloxacin and norfloxacinJournal of Medical Microbiology, 1987
- In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1986
- Pharmacokinetics of a new quinolone, AM-833, in mice, rats, rabbits, dogs, and monkeysAntimicrobial Agents and Chemotherapy, 1986
- In vitro activity of Ro 23-6240, a new fluorinated 4-quinoloneAntimicrobial Agents and Chemotherapy, 1986
- Correlation between growth curve and killing curve of Escherichia coli after a brief exposure to suprainhibitory concentrations of ampicillin and piperacillinAntimicrobial Agents and Chemotherapy, 1985